BiotechTube
Home/Lomond Therapeutics/Brian Ledwith
BL

Brian Ledwith

Chief Development Officer

Lomond Therapeutics

Roles

Chief Development OfficeratLomond Therapeutics
Chief Development OfficeratEilean Therapeutics

Therapeutic Areas

OncologyHematology

Lomond Therapeutics Pipeline

DrugIndicationPhase
lomonitinibAcute Myeloid Leukemia (AML)IND-Enabling
lonitoclaxChronic Lymphocytic Leukemia (CLL)Phase 1
Menin InhibitorAcute Myeloid Leukemia (AML)Discovery

Leadership Team at Lomond Therapeutics

ID
Iain Dukes
CEO
NS
Nikolay Savchuk
COO
AB
Amy Burd
CSO
FP
Fraser Pickersgill
Head CMC
JB
John Byrd
Interim Chief Medical Officer
View full Lomond Therapeutics profile